22nd Century Group Inc (XXII) Sees Large Growth in Short Interest

22nd Century Group Inc (NYSE:XXII) was the recipient of a large increase in short interest during the month of July. As of July 31st, there was short interest totalling 4,270,676 shares, an increase of 5.6% from the July 14th total of 4,043,690 shares. Based on an average trading volume of 2,370,691 shares, the days-to-cover ratio is currently 1.8 days. Approximately 5.8% of the company’s stock are sold short.

In other 22nd Century Group news, VP Michael Robert Moynihan sold 29,532 shares of the company’s stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $2.00, for a total transaction of $59,064.00. Following the completion of the transaction, the vice president now owns 917,220 shares of the company’s stock, valued at approximately $1,834,440. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Virtu KCG Holdings LLC boosted its position in shares of 22nd Century Group by 300.9% in the second quarter. Virtu KCG Holdings LLC now owns 126,106 shares of the biotechnology company’s stock valued at $221,000 after buying an additional 94,650 shares during the last quarter. Vanguard Group Inc. boosted its position in shares of 22nd Century Group by 17.6% in the second quarter. Vanguard Group Inc. now owns 2,894,322 shares of the biotechnology company’s stock valued at $5,065,000 after buying an additional 432,450 shares during the last quarter. Northern Trust Corp boosted its position in shares of 22nd Century Group by 22.3% in the second quarter. Northern Trust Corp now owns 133,797 shares of the biotechnology company’s stock valued at $234,000 after buying an additional 24,401 shares during the last quarter. Finally, National Asset Management Inc. boosted its position in shares of 22nd Century Group by 13.7% in the first quarter. National Asset Management Inc. now owns 172,000 shares of the biotechnology company’s stock valued at $204,000 after buying an additional 20,700 shares during the last quarter.

22nd Century Group (NYSE XXII) opened at 2.30 on Friday. The firm’s 50-day moving average price is $1.79 and its 200-day moving average price is $1.38. The firm’s market cap is $236.35 million. 22nd Century Group has a 52-week low of $0.81 and a 52-week high of $2.84.

Separately, Zacks Investment Research raised 22nd Century Group from a “sell” rating to a “buy” rating and set a $2.00 price target for the company in a research report on Saturday, July 1st.

ILLEGAL ACTIVITY WARNING: This article was first published by Community Financial News and is the sole property of of Community Financial News. If you are viewing this article on another site, it was illegally copied and reposted in violation of U.S. & international copyright & trademark laws. The original version of this article can be viewed at https://www.com-unik.info/2017/08/12/22nd-century-group-inc-xxii-sees-large-growth-in-short-interest.html.

22nd Century Group Company Profile

What are top analysts saying about 22nd Century Group Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for 22nd Century Group Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit